Revelation Partners

Selected news for the capital firm - Revelation Partners, collected since 11/2019. Recent stories appear in Yahoo News. We are still establishing healthcare news links for this capital firm.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics

Selected Headlines

Date Headline (link) Source Relevant Snippet
3/30/2021 Revelation Partners is Lead Investor Backing Rosetta Capital to Purchase Seven Biotech Assets From Schroder UK Public Private Trust plc Yahoo News ... in private healthcare companies giving counterparties the flexibility to manage their illiquid, private investments. These counterparties typically include corporations, venture capital firms, individuals and limited partners in investment funds. As part of that offering, Revelation Partners frequently partners with healthcare focused fund managers such as Rosetta in order to craft the best solution for its counterparties.Scott Halsted , Managing Partner, Revelation Partners , said, "We are pleased to work closely with ...
3/30/2021 Revelation Partners is Lead Investor Backing Rosetta Capital to Purchase Seven Biotech Assets From Schroder UK Public Private Trust plc Yahoo News ... in private healthcare companies giving counterparties the flexibility to manage their illiquid, private investments. These counterparties typically include corporations, venture capital firms, individuals and limited partners in investment funds. As part of that offering, Revelation Partners frequently partners with healthcare focused fund managers such as Rosetta in order to craft the best solution for its counterparties.Scott Halsted , Managing Partner, Revelation Partners , said, "We are pleased to work closely with ...
3/30/2021 Revelation Partners is Lead Investor Backing Rosetta Capital to Purchase Seven Biotech Assets From Schroder UK Public Private Trust plc | Markets Insider Business Insider ... in private healthcare companies giving counterparties the flexibility to manage their illiquid, private investments. These counterparties typically include corporations, venture capital firms, individuals and limited partners in investment funds. As part of that offering, Revelation Partners frequently partners with healthcare focused fund managers such as Rosetta in order to craft the best solution for its counterparties. Scott Halsted , Managing Partner, Revelation Partners , said, "We are pleased to work closely with ...
3/30/2021 Revelation Partners is Lead Investor Backing Rosetta Capital to Purchase Seven Biotech Assets From Schroder UK Public Private Trust plc | Markets Insider Business Insider ... in private healthcare companies giving counterparties the flexibility to manage their illiquid, private investments. These counterparties typically include corporations, venture capital firms, individuals and limited partners in investment funds. As part of that offering, Revelation Partners frequently partners with healthcare focused fund managers such as Rosetta in order to craft the best solution for its counterparties. Scott Halsted , Managing Partner, Revelation Partners , said, "We are pleased to work closely with ...
3/19/2021 AXA backs Gravie coverager.com AXA Venture Partners Gravie AXA backs GravieMinneapolis-based benefits company Gravie has raised $28 million in a Series D round of financing led by AXA Venture Partners (AVP), with participation from existing investors FirstMark Capital, Split Rock Ventures and Revelation Partners .“We are excited to partner with AXA Venture Partners in our mission to heal our broken healthcare system. Over the past couple of years, we have grown revenue ...
3/18/2021 Gravie Secures $28 Million in Financing Led by AXA Venture Partners PR Newswire ... contribution healthcare, today announced that they have raised $28 million in a Series D round of financing led by AXA Venture Partners (AVP), with participation from existing investors FirstMark Capital, Split Rock Ventures and Revelation Partners . The capital will be used to fuel Gravie's continued growth through investments in product and technology, sales and marketing, and expansion into new markets through new and existing distribution channels."We are excited to ...
3/18/2021 Gravie Secures $28 Million in Financing Led by AXA Venture Partners vcaonline.com ... contribution healthcare, today announced that they have raised $28 million in a Series D round of financing led by AXA Venture Partners (AVP), with participation from existing investors FirstMark Capital, Split Rock Ventures and Revelation Partners . The capital will be used to fuel Gravie's continued growth through investments in product and technology, sales and marketing, and expansion into new markets through new and existing distribution channels. "We are excited to ...
3/18/2021 Revelation Partners targets illiquid healthcare private capital boom with $350m hard cap Fund III close altassets.net ... managing partner Scott Halsted said, “With the tremendous amount of private capital that has flowed into the healthcare space over the last several years, our limited partners continue to see the attractive opportunity for Revelation Partners to provide liquidity in this illiquid market.”The firm also announced three recent appointments, in the promotion of Fred Lee to managing director and hires of Doug Fisher as venture partner and Suchira ...
3/16/2021 Financings for March 16, | 2021-03-16 BioWorld Med-tech firms raising money in public or private financings, including: Clarify Health, Glooko, Nephrosant, Revelation Partners ...
3/16/2021 Revelation Partners Closes Revelation Healthcare Fund III at Hard Cap of $350MM | Markets Insider Business Insider SAN FRANCISCO , March 16, 2021 /PRNewswire/ -- Revelation Partners , a dedicated secondary investor in healthcare, announced the first and final closing of its newest fund, Revelation Healthcare Fund III, at its hard cap of $350 million . The oversubscribed offering surpassed the initial target of $300 million and builds on the long-term investment success of the firm. The firm, which now manages over $900 million of committed capital, specializes in providing ...
3/2/2021 After $31M Raise, Nuvolo Eyes IPO As Early As 2023 crunchbase.com ... founder and CEO Tom Stanford .Insight Partners led the Series C raise for the Paramus, New Jersey-based workplace services company. Other investors in the round include New Enterprise Associates , Kaiser Permanente Ventures and Revelation Partners .“Nuvolo is exactly the kind of company we partner with,” said Henry Frankievich , principal at Insight Partners. “They have a great product with a huge market. Nuvolo is in that very exciting growth ...
1/28/2021 SetPoint Gives a Jolt to RA Pivotal Trial with New Financing MDDI ... Venture Capital, Boston Scientific, Topspin Fund, Morgenthaler, Euclidean Capital, and an undisclosed strategic investor.New investors including ShangBay Capital, Richard King Mellon Foundation, Ascendum Capital, Asahi Kasei, Catalio Capital Management, BPC Fund, Midas Capital, Revelation Partners , Aethan Capital, Citta Capital, and SVE Capital also participated in this round. William Dai, Founding Managing Partner at ShangBay Capital, has joined SetPoint Medical’s Board of Directors in conjunction with this financing. The ...
1/27/2021 SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform vcaonline.com ... Venture Capital, Boston Scientific, Topspin Fund, Morgenthaler, Euclidean Capital and an undisclosed strategic investor. New investors including ShangBay Capital, Richard King Mellon Foundation, Ascendum Capital, Asahi Kasei, Catalio Capital Management, BPC Fund, Midas Capital, Revelation Partners , Aethan Capital, Citta Capital and SVE Capital also participated in this round. William Dai, Founding Managing Partner at ShangBay Capital, has joined SetPoint Medical’s Board of Directors in conjunction with this financing. The ...
12/22/2020 SomaLogic Adds $81 Million to Series A Financing Totaling $214 Million aithority.com ... Monashee Investment Management, Mossrock Capital, Soleus Capital and others.Recommended AI News: CloudRadial Announces IT Assessments Module For ComplianceIn this second close, additional financial investors include Janus Henderson Investors, Redmile Group, Logos Capital, Revelation Partners , Ziff Capital Healthcare Ventures, Boston Millennia Partners and Millennium Management. Strategic investors from a number of premier organizations that span the current and future proteomics market include Novartis, Amgen, Intermountain Ventures and NEC Solution ...
12/22/2020 SomaLogic Adds $81M to Series A Financing Totaling $214M vcaonline.com ... Management, Fiscus Ventures and Reimagined Ventures (affiliates of Magnetar Capital), Monashee Investment Management, Mossrock Capital, Soleus Capital and others. In this second close, additional financial investors include Janus Henderson Investors, Redmile Group, Logos Capital, Revelation Partners , Ziff Capital Healthcare Ventures, Boston Millennia Partners and Millennium Management. Strategic investors from a number of premier organizations that span the current and future proteomics market include Novartis, Amgen, Intermountain Ventures and NEC Solution ...
9/3/2020 Neurostimulation therapy startup NeuroPace closes $33M raise with extra $34M in debt financing – Safety Health News MobiHealthNews NeuroPace, the maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, announced a $33 million equity raise on Monday. Accelmed Partners led the investment, which was joined by new backers such as Revelation Partners , Soleus Capital and an unnamed strategic investor. Prior backers KCK Group and OrbiMed Advisors also contributed. Alongside the equity, NeuroPace said that it also received $34 million in convertible debt financing from other prior ...
9/2/2020 Neurostimulation therapy startup NeuroPace closes $33M raise with extra $34M in debt financing MobiHealthNews ... NeuroPace, the maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, announced a $33 million equity raise on Monday. Accelmed Partners led the investment, which was joined by new backers such as Revelation Partners , Soleus Capital and an unnamed strategic investor. Prior backers KCK Group and OrbiMed Advisors also contributed. Alongside the equity, NeuroPace said that it also received $34 million in convertible debt financing from other prior ...
8/31/2020 NeuroPace Raises $67 Million Financing to Support Commercial Expansion of the RNS® System for Refractory Epilepsy Business Wire MOUNTAIN VIEW, Calif.- NeuroPace, Inc. , a Silicon Valley-based medical technology company, today announced it has raised $67 million in a funding round led by Accelmed Partners with participation from an unnamed strategic investor, Revelation Partners , Soleus Capital, and returning investors KCK Group and OrbiMed Advisors. The financing includes $33 million of new equity capital and $34 million from convertible debt provided by current investors from a prior funding round ...
8/31/2020 malvern-online.com NeuroPace, Inc. , a Silicon Valley-based medical technology company, today announced it has raised $67 million in a funding round led by Accelmed Partners with participation from an unnamed strategic investor, Revelation Partners , Soleus Capital, and returning investors KCK Group and OrbiMed Advisors. The financing includes $33 million of new equity capital and $34 million from convertible debt provided by current investors from a prior funding round. An additional $27 ...
8/31/2020 NeuroPace Raises $67 Million Financing to Support Commercial Expansion of the RNS® System for Refractory Epilepsy BioSpace MOUNTAIN VIEW, Calif.--( BUSINESS WIRE )-- NeuroPace, Inc. , a Silicon Valley-based medical technology company, today announced it has raised $67 million in a funding round led by Accelmed Partners with participation from an unnamed strategic investor, Revelation Partners , Soleus Capital, and returning investors KCK Group and OrbiMed Advisors. The financing includes $33 million of new equity capital and $34 million from convertible debt provided by current investors from a prior ...